Surgical staging endometrial cancer

Clinical Obstetrics and Gynecology

Volumn 39, Issue 3, 1996, Pages 656-668

  Orr Jr , James W ^a,b,d   Orr, Pamela F ^b   Taylor, Peyton T ^c  

^a Columbia Reg Med Ctr SW Florida ^*  (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

^d FACS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RISK; CANCER STAGING; CANCER SURGERY; ENDOMETRIUM CANCER; FEMALE; HUMAN; LYMPH NODE METASTASIS; MORBIDITY; OBSTETRIC OPERATION; PREOPERATIVE EVALUATION; REVIEW; RISK ASSESSMENT;

ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; HYSTERECTOMY; LYMPHATIC METASTASIS; NEOPLASM STAGING; TREATMENT OUTCOME;

EID: 0029779733     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003081-199609000-00014     Document Type: Review

References (73)

1. Corn BW, Lanciano RM, Greven KM, et al. Impact of improved radiation technique, age, and lymph node sampling on the severe complication rate of surgically staged endometrial cancer patients: a multivariate analysis. J Clin Oncol. 1994;12:510-515.
2. Mikuta JJ. International Federation of Gynecology and Obstetrics staging of endometrial cancer 1988. Cancer. 1993;71:1460-1463.
3. Lewis BV, Stallworthy JA, Dowdell R. Adenocarcinoma of the body of the uterus. J Obstet Gynecol Br Commonw. 1970;77:343.
4. Aalders J, Abeler V, Kolstad P, Onsrud M. Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma. Obstet Gynecol. 1980;56:419-426.
5. DiSaia PJ, Creasman WT, Boronow RC and Blessing JA. Risk factors and recurrent patterns in stage I endometrial cancer. Am J Obstet Gynecol. 1985;141:1009-1015.
6. Zaino RJ, Kurman RJ, Diana KL, Morrow CP. The utility of the revised International Federation of Gynecology and Obstetrics histologic grading of endometrial adenocarcinoma using a defined nuclear grading system. A Gynecologic Oncology Group Study. Cancer. 1995;75:81-86.
7. Wolfson AH, Sightler SE, Markoe AM, et al. The prognostic significance of surgical staging for carcinoma of the endometrium. Gynecol Oncol. 1992;45:142-146.
8. Lanciano RM, Corn BW, Schultz DJ, et al. The justification for a surgical staging system in endometrial carcinoma. Radiotherapy and Oncology. 1993;28:189-196.
9. Chuang L, Burke TW, Tornos C, et al. Staging laparotomy for endometrial carcinoma: assessment of retroperitoneal lymph nodes. Gynecol Oncol. 1995;58:189-193.
10. Kilgore LC, Partridge EE, Alvarez RD, Austin J, Shingleton H, Noojin F, Coner W. Adenocarcinoma of the endometrium: survival comparison of patients with and without pelvic node sampling. Gynecol Oncol. 1995;56:29-33.
11. George E, Lillemoe TJ, Twiggs LB, Perrone T. Malignant mixed mullerian tumor versus high grade endometrial carcinoma and aggressive variants of endometrial carcinoma: a comparative analysis of survival. Int J Gynecol Pathol. 1995;14:39-44.
12. Rosenberg P, Blom R, Hogberg T, Simonsen E. Death rate and recurrence pattern among 841 clinical stage I endometrial cancer patients with special reference to uterine papillary serous carcinoma. Gynecol Oncol. 1993;51:311-315.
13. Carcangiu ML and Chambers JT. Early pathologic stage clear cell carcinoma and uterine papillary serous carcinoma of the endometrium: comparison of clinicopathologic features and survival. Int J Gynecol Pathol. 1995;14:30-38.
14. DeBeshter B, Warshal DP, Angel C, Doretsky PM, Lin JY, Raubertas RF. Endometrial carcinoma: the relevance of cervical cytology. Obstet Gynecol. 1991;77:458-462.
15. Larson DM, Johnson KK, Reyes CN Jr, Broste SK. Prognostic significance of malignant cervical cytology in patients with endometrial cancer. Obstet Gynecol. 1994;84:399-403.
16. Orr Jr JW, Holloway RW, Orr PF, Holimon JL. Surgical staging of uterine cancer: an analysis of perioperative morbidity. Gynecol Oncol. 1991;42:209-216.
17. Patsner B, Mann WJ, Cohen H, Loesch H. Predictive value of preoperative CA125 levels in clinically localized and advanced endometrial cancer. Am J Obstet Gynecol. 1988;158:399-402.
18. Takeshima N, Shimizu Y, Umezawa S, et al. Combined assay of serum levels of CA125 and CA19-9 in endometrial carcinoma. Gynecol Oncol. 1994;54:321-326.
19. Rose PG, Sommers RM, Reale FR, et al. Serial serum CA125 measurements for evaluation of recurrence in patients with endometrial carcinoma (review). Obstet Gynecol. 1994;84:12-16.
20. Patsner B and Orr Jr JW. Use of serum CA125 measurement in post-treatment surveillance of early stage endometrial cancer. Am J Obstet Gynecol. 1990;162:427-429.
21. Orr Jr JW, Orr PJ. Pulmonary complications. In: Orr JW, Shingleton HM, eds. Complications of Gynecologic Surgery: Prevention, Recognition and Management. Philadelphia: J.B. Lippincott, 1994.
22. Cowles TQ, Magrina JF, Masterson BJ, et al. Comparison of clinical and surgical staging in patients with endometrial carcinoma. Obstet Gynecol. 1985;66:413.
23. Abayomi O, Dritschlo A, Emami B, et al. The value of "routine tests" in the staging evaluation of gynecologic malignancies: a cost effectiveness analysis. Int J Rad Oncol Biol Phys. 1982;8:241-244.
24. Partridge EE. Endometrial cancer, changing concepts in therapy. Surg Clin North Am. 1991;71:991-1004.
25. Atsukawa H, Sasaki H, Tada S. A multivariate analysis of assessment of myometrial invasion of endometrial carcinoma by magnetic resonance imaging. Gynecol Oncol. 1994;54:298-306.
26. Artner A, Bosze P, Gonda G. The value of ultrasound in preoperative assessment of the myometrial and cervical invasion in endometrial carcinoma. Gynecol Oncol. 1994;54:147-151.
27. Chao CK, Grigsby PW, Perez CA, et al. Brachytherapy-related complications for medically inoperable stage I endometrial carcinoma. Int J Rad Oncol Biol Phys. 1995;31:37-42.
28. Orr Jr JW, Sisson PF, Patsner B, et al. Single dose antibiotic prophylaxis for patients undergoing extended pelvic surgery for gynecologic malignancy. Am J Obstet Gynecol. 1990;162:718-721.
29. Orr Jr JW and Taylor PT. Reducing postoperative infection in the patient with gynecologic cancer. Infections in Surgery. 1987;6:666.
30. Creasman WT, Morrow CP, Bundy BN, Homesley HD, et al. Surgical pathologic spread patterns of endometrial cancer. A gynecologic oncology group study. Cancer. 1987;60:2035-2041.
31. Morrow CP, Bundy BN, Kurman RJ, Creasman WT, et al. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a gynecologic oncology group study. Gynecol Oncol. 1991;40:55-65.
32. Berek JS, Hacker NF, Hatch KD, Young RC. Uterine corpus and cervical cancer. Curr Probl Cancer. 1988;XII:65.
33. Chen SS, Spiegel G. Stage I endometrial carcinoma. Role of omental biopsy and omentectomy. J Reprod Med. 1991;36:627-629.
34. Bosscher J, Barnhill D, O'Connor D, Park R. Case report: clinical stage IB endometrial adenocarcinoma with an isollated small bowel metastasis. Gynecol Oncol. 1994;52:99-101.
35. Girardi F, Petru E, Heydarfadai M, et al. Pelvic lymphadenectomy in the surgical treatment of endometrial cancer. Gynecol Oncol. 1993;49:177-180.
36. Vardi JR, Tadros GH, Anselmo MT, Rafla SD. The value of exploratory laparotomy in patients with endometrial carcinoma according to the new International Federation of Gynecology and Obstetrics staging. Obstet Gynecol. 1992;80:204-208.
37. 36a.Belinson JL, Lee KR, Badget GJ, et al. Clinical stage I adenocarcinoma of the endometrium - analysis of recurrences and the potential benefit of staging lymphadenectomy. Gynecol Oncol. 1992;44:17-23.
38. Kim YB, Niloff JM. Endometrial carcinoma: analysis of recurrence in patients treated with a strategy minimizing lymph node sampling and radiation therapy. Obstet Gynecol. 1993;82:175-180.
39. Carey MS, O'Connell GI, Kohanson CR, et al. Good outcome associated with a standardized treatment protocol using selective postoperative radiation in patients with clinical stage I adenocarcinoma of the endometrium. Gynecol Oncol. 1995;57:138-144.
40. Goff BA, Rice LW. Assessment of depth of myometrial invasion in endometrial adenocarcinoma. Gynecol Oncol. 1990;38:46-48.
41. Malviya VK, Deppe G, Malone JM, et al. Reliability of frozen section examination in identifying poor prognostic indicators in stage I endometrial adenocarcinoma. Gynecol Oncol. 1989;34:299-304.
42. Zorlu CG, Kuscu E, Ergun Y, et al. Intraoperative evaluation of prognostic factors 34 stage I endometrial cancer by frozen section: how reliable? Acta Obstet Gynecol Scand. 1993;72:392-395.
43. Fanning J, Tsukada Y, Piver MS. Intraoperative frozen section diagnosis of depth of myometrial invasion in endometrial adenocarcinoma. Gynecol Oncol. 1990;37:47-50.
44. Lampe B, Kurzl R, Hantschmann P. Prognostic factors that predict pelvic lymph node metastasis from endometrial carcinoma. Cancer. 1994;74:2502-2508.
45. Faught W, Krepart GV, Lotocki R, Heywood M. Should selective paraaortic lymphadenectomy be part of surgical staging for endometrial cancer? Gynecol Oncol. 1994;55:51-55.
46. Rose PG, Cha SD, Tak WK, Fitzgerald T, et al. Radiation therapy for surgically proven paraaortic node metastasis in endometrial carcinoma. Int J Rad Oncol Biol Phys. 1992;24:229-233.
47. Corn BW, Lanciano RM, Goffen KM, Schultz DJ, Reisinger SA, et al. Endometrial cancer with paraaortic adenopathy: patterns of failure and opportunity for cure. Int J Rad Oncol Biol Phys. 1992;24:223-227.
48. Gynecologic Oncology Group Surgery Manual. Philadelphia: Gynecologic Oncology Group, 1994.
49. Daniel AG, Peters WA. Accuracy of office and operating room curettage in the grading of endometrial carcinoma. Obstet Gynecol. 1988;71:612.
50. Lampe B, Kurzl R, Hantschmann P. Reliability of tumor typing of endometrial car- cinoma in prehysterectomy curettage. Int J Gynecol Pathol. 1995;14:2-6.
51. Larson DM, Johnson KK, Broste SK, Krawisz BR, Kresl JJ. Comparison of D&C ad office endometrial biopsy in predicting final histopathologic grade in endometrial cancer.
52. Calais G, Descamps P, Vitu L, Body G, et al. Is lymphadenectomy useful in the treatment of endometrial carcinoma? Gynecol Oncol. 1990;38:71-75.
53. Lin HH, Chen CD, Chen CK, Chen CL, Chow SN, Huang SC. Is total abdominal hysterectomy with bilateral salpingo-oophorectomy adequate for new FIGO stage I endometrial carcinoma? Br J Obstet Gynaecol. 1995;102:148-152.
54. Babilonti L, DiPietro G, LaFianza A, et al. Complications of pelvic lymphadenectomy in patients with endometrial adenocarcinoma. Eur J Gynaecol Oncol. 1989;2.
55. Pisani AL, Barbuto DA, Chen D, Ramos L, Lagasse LD, Karlan BY. HER-2/neu, p53, and DNA analysis as prognosticators for survival in endometrial carcinoma. Obstet Gynecol. 1995;85:729-734.
56. Pfisterer J, Kommoss F, Sauerbrei W, et al. Prognostic value of DNA ploidy and S-phase fraction in stage I endometrial carcinoma. Gynecol Oncol. 1995;58:149-156.
57. Sutton GP, Geisler HE, Stehman FB, et al. Features associated with survival and disease-free survival in early endometrial cancer. Am J Obstet Gynecol. 1989;160:1385-1393.
58. Rosenberg P, Blom R, Hogberg T, Simonsen E. Death rate and recurrence pattern among 841 clinical stage I endometrial cancer patients with special reference to uterine papillary serous carcinoma. Gynecol Oncol. 1993;51:311-315.
59. Aalders JG, Neijt JP. Aspects of surgery in ovarian and endometrial carcinoma. Eur J Cancer. 1993;29A:624-628.
60. Marino BD, Burke TW, Tornos C, et al. Staging laparotomy for endometrial carcinoma: assessment of peritoneal spread. Gynecol Oncol. 1995;56:34-38.
61. Orr Jr JW, Barter JF, Kilgore LC, et al. Closed suction pelvic drainage after radical pelvic surgical procedures. Am J Obstet Gynecol. 1986;155:867-871.
62. Bennedetti-Panici P, Maneschi F. Scotto di Palumbo V, Scambia G, et al. Lymphade- nectomy in gynecologic oncology: to drain or not to drain the retroperitoneaum. Abstract, Biennial Meeting of the International Gynecologic Cancer Society, September 4-8, 1995, Philadelphia, PA.
63. Franchi M, Zanaboni F, et al. Role of peritonealization in radical hysterectomy and node dissection (RHND): a multicenter randomized study. Abstract 5, Biennial Meeting of the International Gynecologic Cancer Society, September 4-8, 1995, Philadelphia, PA.
64. Orr Jr JW, Orr PF, Barrert JM, Ellington JR, Jennings RH, Paredes K, Patsner B, Taylor DL. Fascial closure: continuous or interrupted? A prospective evaluation of #1 Maxon suture in 402 gynecologic procedures. Am J Obstet Gynecol. 1990;163:1485-1489.
65. Foley K, Lee RB. Surgical complications of obese patients with endometrial carcinoma. Gynecol Oncol. 1990;39:171-174.
66. Orr JW Jr, Shignleton HM, eds. Complications in Gynecologic Surgery: Prevention, Recognition and Management. Philadelphia: J.B. Lippincott, 1994.
67. Pitkin RM. Abdominal hysterectomy in obese women. Surg Gynecol Obstet. 1976;142:532-536.
68. Chen SA. Operative treatment in stage I endometrial carcinoma with deep myometrial invasion and/or grade 3 tumor surgically limited to the corpus uteri. Cancer. 1985;63:1943-1945.
69. Holowaty EJ, Darlington GA, Gajalakshmi CK, Toogood PB, Levin Wilfred. Leukemia after irradiation for endometrial cancer in Onario. Cancer. 1995;76:644-649.
70. Torrisi JR, Barnes WA, Popescu G, et al. Postoperative adjuvant external beam radiotherapy in surgical stage I endometrial carcinoma. Cancer. 1989;64:1414-1417.
71. Homesly HO, Zarno R. Endometrial cancer: prognostic factors. Semin Oncol. 1994;21:71-78.
72. Burke TW, Wolfson AH. Limited endometrial carcinoma: adjuvant therapy. Semin Oncol. 1994;41:84-90.
73. Elliott P, Green D, Coates A, Krieger M, et al. The efficacy of postoperative vaginal irradiation in preventing vaginal recurrence in endometrial cancer. Int J Gynecol Cancer. 1994;4:84-93.